This research study is looking at different ways to manage pain after minimally invasive cancer surgery for conditions like liver (hepatic), stomach (gastric), or other abdominal cancers. You could be eligible if you are between 18 and 89 years old and are scheduled for one of these surgeries. The study will compare three pain management approaches: Laparoscopic Transversus Abdominis Plane Block (LapTAP) with local anesthesia (ropivacaine), LapTAP alone, or local anesthesia (ropivacaine) alone. The main goal is to see how well each method controls your pain, measured hourly for 24 hours after surgery and again when you leave the hospital. This study aims to find the best way to manage pain for patients like you.

Study design

This study plans to enroll 48 participants and will randomly assign them to one of three pain management groups, like flipping a coin.

What's involved

You will undergo all standard pre-operative tests and procedures. The research team will collect data from your medical records.

Compensation

Not stated in the trial record.

Follow-up

Your pain will be measured hourly for 24 hours after surgery, and again at the time of hospital discharge (on average 1 week).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.